Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN)
Project Number5D43TW012246-03
Contact PI/Project LeaderWEAVER, SCOTT C Other PIs
Awardee OrganizationUNIVERSITY OF TEXAS MED BR GALVESTON
Description
Abstract Text
ABSTRACT
Emerging viral diseases comprise several of the greatest global risks to human health, and West Africa is a
source and epicenter for several. These include arthropod-borne viruses (arboviruses), such as chikungunya,
Zika, and yellow fever with African origin and both ancient and recent histories of spread to Asia and the Americas
to initiate massive epidemics. Dengue also increasingly recognized in Africa as a major public health problem.
Zoonotic African hemorrhagic viruses also caused unprecedented outbreaks during the past decade. In 2014,
the first West African epidemic of hemorrhagic fever attributed to Ebola virus spread to several countries
including Sierra Leone, representing by far the most devastating filoviral outbreak on record with over 11,000
fatalities. Lassa virus, causing an estimated 100,000-300,000 hemorrhagic fever cases in Africa annually,
produced an unprecedented 2018-2019 epidemic in Nigeria. The mechanisms whereby these zoonotic viruses
emerge remain obscure along with understanding of their true disease burden and varied clinical disease and
sequelae outcomes. To address these challenges, we will develop a new generation of West African scientists
to predict, prevent and contain emerging viral diseases through multidisciplinary scientific and public health
training. Leveraging our West African Center for Emerging Infectious Diseases (WAC-EID, NIAID U01AI151801),
outstanding research leaders in West Africa, and the exceptional breadth of expertise in emerging viral diseases
at the University of Texas Medical Branch (UTMB), we will provide multidisciplinary training for young scientists
from two leading universities: Njala University in Sierra Leone and Jos University in Nigeria. The aims of Training
and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) include: 1. Provide general
on-site training at Njala and Jos Universities to Master’s/PhD students enrolled in the local graduate programs;
2. Provide specialized training at UTMB on the most advanced methods and techniques for expertise transfer to
Sierra Leone and Nigeria; 3. Provide on-site research training at Njala and Jos Universities to ensure successful
local implementation of the program, which will include education of laboratory technicians/managers among
others; 4. Integrate trainees into the WAC-EID’s research programs to gain hands-on experience in surveillance
activities, diagnostics and data management. Five trainees per year will participate in short-, medium-, and long-
term training phases at UTMB and in W. Africa. Training activities will include didactic courses, online modules,
field training, molecular/virological techniques including the study of animal models and pathogenesis, biosafety
training, and lab management education. Upon the completion of our training program, these young scientists
will play critical roles in surveillance to better understand the circulation of emerging viruses in the region,
mechanisms of emergence, virus discovery, epidemic transmission, pathogenesis, and countermeasures to
mitigate emerging viral threats. The local training programs are designed to be sustainable, and the 3-way
research and training partnerships will broadly benefit science and public health throughout the region.
Public Health Relevance Statement
PROJECT NARRATIVE
Emerging viral diseases threaten human health globally, and West Africa is a source and major epidemic location
for many. We will develop a new generation of West African scientists to predict, prevent and contain emerging
viral diseases through multidisciplinary scientific and public health training by leveraging the resources of our
West African Center for Emerging Infectious Diseases, outstanding research leaders in West Africa, and the
exceptional breadth and depth of expertise in emerging viral diseases at the University of Texas Medical Branch
(UTMB).
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAfricaAfricanAmericasAnimal ModelArbovirusesAsiaChikungunya feverCirculationClinicalCountryDengueDiagnosticDiseaseDisease OutbreaksEbola virusEducationEmerging Communicable DiseasesEnrollmentEnsureEpidemicGenerationsHealthHemorrhageHemorrhagic Fever with Renal SyndromeHumanLaboratory TechniciansLassa virusMedicalMethodsMolecularNational Institute of Allergy and Infectious DiseaseNigeriaOutcomePathogenesisPhasePlayPublic HealthPublic Health EducationRecording of previous eventsResearchResearch TrainingRiskRoleScienceScientistSierra LeoneSiteSourceTechniquesTexasTrainingTraining ActivityTraining ProgramsUniversitiesViralViral Hemorrhagic FeversVirusVirus DiseasesYellow FeverZoonosesarthropod-borneburden of illnessdata managementdesigndoctoral studentemerging virusexperiencemultidisciplinarypreventprogramstransmission processzika fever
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
989
DUNS Number
800771149
UEI
MSPWVMXXMN76
Project Start Date
01-March-2022
Project End Date
28-February-2027
Budget Start Date
01-March-2024
Budget End Date
28-February-2025
Project Funding Information for 2024
Total Funding
$248,400
Direct Costs
$234,314
Indirect Costs
$14,086
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$50,000
2024
John E. Fogarty International Center for Advanced Study in the Health Sciences
$198,400
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5D43TW012246-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5D43TW012246-03
Patents
No Patents information available for 5D43TW012246-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5D43TW012246-03
Clinical Studies
No Clinical Studies information available for 5D43TW012246-03
News and More
Related News Releases
No news release information available for 5D43TW012246-03
History
No Historical information available for 5D43TW012246-03
Similar Projects
No Similar Projects information available for 5D43TW012246-03